Navigation Links
Turning on cell-cell communication wipes out staph biofilms
Date:4/30/2008

University of Iowa researchers have succeeded in wiping out established biofilms of Staphylococcus aureus (staph) by hijacking one of the bacteria's own regulatory systems. Although the discovery is not ready for clinical application, the findings offer insight into a dispersal mechanism for staph biofilms and might help identify therapeutic targets.

Biofilms are communities of bacteria that grow on moist surfaces, including heart valves, bone and medical implants. Encased in self-produced slime and highly resistant to antibiotic therapy and the body's own immune defenses, biofilm infections represent a tough and dangerous medical problem. The findings were published in the journal Public Library of Science Pathogens (PLoS-Pathogens) on April 25.

"We have shown that activating the cells' communication system, also known as quorum sensing, in established biofilms causes the biofilms to disperse rapidly," said Alexander Horswill, Ph.D., UI assistant professor of microbiology and senior study author. "This is the first report of an existing dispersal pathway in Staph aureus. If we can tap into this mechanism, then that might lead to better treatments."

Quorum sensing is the mechanism bacteria use for cell-to-cell signaling. This communication system allows bacteria to react to environmental changes in order to survive and thrive. In Staphylococcus aureus, the quorum-sensing system is turned on by autoinducing peptides (AIPs), small molecules that contain an unusual cyclic structure and are shaped like a ring with a tail.

Previous research, including work done at the UI, suggested that this quorum-sensing system was involved in biofilm detachment, but it was difficult to test the idea because there was no good way to make AIPs.

That is where Horswill's expertise came in. In earlier research he had developed an enzymatic approach for manufacturing cyclic peptides. Using this chemistry, he was able to prepare large quantities of the pure AIPs, which allowed the team to conduct biofilm dispersal experiments.

"Figuring out how to synthesize these signal molecules so that we could do the dispersal experiments was a real breakthrough," he said. "We used this new method to make AIP, added it directly to established biofilms and watched them blow apart. And that's when the excitement started."

Having established that activation of the quorum-sensing system in established biofilms triggers dispersal of the biofilm, the UI team has started to investigate the details of the mechanism. In particular, they discovered the mechanism depended on the presence of active proteases -- enzymes that break down proteins.

"If we can learn more about how the system works, then that might suggest new therapeutic targets," said Blaise Boles, Ph.D., UI postdoctoral research fellow.

Importantly, Horswill and Boles also showed that bacteria released from the biofilm were once again susceptible to antibiotics, which raises possibilities for improving treatments for chronic biofilm infections.

"Current treatment for endocarditis -- a potentially life threatening infection where a staph biofilm forms on heart valves -- involves weeks of intravenous antibiotics, and sometimes requires surgery," Boles explained. "One thing we'd like to test is whether we can treat biofilms in models of diseases like endocarditis by turning on quorum sensing."

Horswill added that he plans to start a collaborative effort with Jose Morcuende, M.D., Ph.D., UI associate professor of orthopaedics and rehabilitation, to investigate the dispersal of staph biofilms from both allograft bone and medical implant materials.

The findings also may have implications for treating biofilms of emerging antibiotic resistant staph strains, including methicillin-resistant Staphylococcus aureus (MRSA).

Although the team has not tested their dispersal methods on MSRA, Horswill notes that the MRSA stains are quite similar to the lab strains he and Boles tested and have quorum-sensing systems that are even more active than those of the lab strains. This suggests that MRSA might be particularly sensitive to approaches that manipulate quorum sensing.

Moving a basic discovery into medically relevant experimental models is an example of translational research of the type supported and encouraged by the new Institute for Clinical and Translational Science at the UI.


'/>"/>

Contact: Jennifer Brown
jennifer-l-brown@uiowa.edu
319-335-9917
University of Iowa
Source:Eurekalert

Related biology news :

1. Cow stomach holds key to turning corn into biofuel
2. Montana State University researcher finds renewed interest in turning algae into fuel
3. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2007 Results
4. Scripps research team blocks bacterial communication system to prevent deadly staph infections
5. 2 French scientists win European award for communication
6. Springer book wins Quality of Communication Award
7. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
8. A private bandwidth for communication in bats: Evidence from insular horseshoe bats
9. Best treatment identified to reduce deadly Staph infections
10. Microbial biofilms evoke Jekyll & Hyde effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... -- Perimeter Surveillance & Detection Systems, Biometrics ... Support & Other Service  The latest report ... analysis of the global Border Security market . ... $17.98 billion in 2016. Now: In November ... software and hardware technologies for advanced video surveillance. ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology: